Michael O'Brien

Michael O'Brien

Nessuna posizione attualmente

Finance
Consumer Services

Profilo

Dr. Michael O'Brien is a Portfolio Manager at Schroder Investment Management North America, Inc. He is responsible for enhancing the Quantitative Equity Products models and explaining our investment approach to our clients.
He moved to the New York office in January 2014 from the Schroder Investment Management Australia Limited Sydney office which he joined in 2008.
While based in Sydney he was focused on enhancing QEP’s stock selection models and implementing research ideas into the investment process.
Prior to joining Schroders, Dr. O'Brien worked for the University of Queensland and University of Sydney for four years in a research and teaching position.
This research focused on Asset Pricing models and the influence of size, value and momentum factors on investment outcomes and lead to the publication of several papers in international finance journals.
In addition he co-founded and developed an accounting database that stored annual report information of Australian stocks from 1981 to 2010 that is in the process of being sold to Sirca, a research institute and data provider in Australia.
Dr. O'Brien holds a PhD in Finance from the University of Queensland, BComm (Hons) in Finance & Economics and a BSc in Biochemistry from the University of Sydney.

Precedenti posizioni note di Michael O'Brien

SocietàPosizioneFine
Gestore di Portafoglio-Azioni 01/09/2020
Analyst-Equity -
Vedi nel dettaglio l'esperienza di Michael O'Brien

Formazione di Michael O'Brien

The University of Queensland Doctorate Degree
The University of Sydney Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael O'Brien

Relazioni

21

Relazioni di 1° grado

4

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private2

Finance

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Michael O'Brien